HomeCOGT • NASDAQ
add
Cogent Biosciences Inc
Previous close
$40.04
Day range
$39.26 - $42.24
Year range
$3.72 - $43.73
Market cap
7.38B USD
Avg Volume
4.16M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 83.36M | 10.53% |
Net income | -80.93M | -14.58% |
Net profit margin | — | — |
Earnings per share | -0.50 | 21.88% |
EBITDA | -82.71M | -10.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 390.89M | 16.50% |
Total assets | 425.93M | 10.92% |
Total liabilities | 123.47M | 78.02% |
Total equity | 302.46M | — |
Shares outstanding | 142.45M | — |
Price to book | 28.81 | — |
Return on assets | -59.48% | — |
Return on capital | -72.02% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -80.93M | -14.58% |
Cash from operations | -64.29M | -23.66% |
Cash from investing | -155.05M | -357.61% |
Cash from financing | 217.37M | 34,734.46% |
Net change in cash | -1.96M | -122.26% |
Free cash flow | -36.38M | -63.77% |
About
Founded
2014
Headquarters
Website
Employees
205
